Pilonidal Sinus Clinical Trial
Official title:
The Role of Mesenchymal Stem Cell and Exosome in Treating Pilonidal Sinus Disease in Children: A Prospective Randomized Controlled Trial
Chronic wounds that fail to heal over extended periods pose a significant financial burden on the healthcare system, underscoring the urgent need to enhance clinical treatments. Among the most promising approaches are stem cell-based therapies. Substantial evidence suggests that mesenchymal stem cells (MSCs) can facilitate the healing of chronic wounds in both animal models and preclinical studies, primarily through their paracrine actions. The bioactive factors and cytokines secreted by MSCs can be harvested in the form of conditioned medium. This medium has been processed into a lyophilized powder for clinical use. Patients with chronic wounds will recruited and divided into two groups: the control group will receive the commonly used fibroblast growth factor, while the experimental group was treated with the lyophilized powder. The study aims to assess the efficacy and safety of this Stem cell and exosome in treating chronic wounds (especially pilonidal sinus).
Pilonidal sinus disease (PSD) is an infectious or inflammatory condition beneath the skin at the peak of the gluteal cleft in the sacrococcygeal area. It is a chronic condition characterized by discharge, infection, and pain. Although it can occur during adolescence, it is most commonly seen in adult males, leading to a focus on adult treatments in research. Surgical treatment was first implemented by Anderson in 1847. Since then, various surgical and medical treatment options have been explored, yet there is no widely accepted standardized treatment. The ideal treatment should be simple, require a short hospital stay, have low recurrence rates, provide good cosmetic results, be cost-effective, cause minimal pain, and allow a quick return to social life, making the surgical approach contentious. Maurice and Greenwood first reported the application of liquid phenol in 1964, initially under general anesthesia, later shifting to local anesthesia. Due to high recurrence rates with liquid phenol, Dogru and colleagues introduced the crystallized phenol (CP) procedure, a minimally invasive method now commonly used in adults. Recent years have shown that stem cells and exosomes promote tissue healing and reduce inflammation. Known for their ability to differentiate into various cell types, stem cells, and exosomes play critical roles in intercellular communication, containing a variety of molecules. Their use in surgical fields has become popular as they speed up the post-operative healing process and reduce the risk of complications. Research in the literature supports that stem cells and exosomes accelerate wound healing (e.g., Nourian Dehkordi A, et al. 2019). This study is based on two main premises: firstly, to identify the potential healing effects of stem cell and exosome applications in treating pilonidal sinus disease; and secondly, to comparatively assess the impact of these applications on surgical outcomes, specifically regarding surgery duration, complications, and the healing process. Comparing these two groups will help determine the value of stem cell and exosome applications in managing pilonidal sinus disease. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT01963273 -
Video Assisted Ablation of Pilonidal Sinus
|
N/A | |
Completed |
NCT00716937 -
Karydakis Procedure Versus Excision With Healing by Secondary Intention (EHSI) in Sacrococcygeal Pilonidal Sinus
|
Phase 4 | |
Completed |
NCT06459739 -
Effect of Sacral Erector Spinae Plane Block on Hemorrhoid and Pilonidal Sinus Surgery
|
N/A | |
Recruiting |
NCT05474911 -
PILONIDAL SINUS: CONVENTIONAL CARE VERSUS NEGATIVE PRESSURE THERAPY.
|
N/A | |
Completed |
NCT04599517 -
The Most Frequently Preferred Surgical Method In The Treatment Of Sacrococcygeal Pilonidal Disease
|
||
Recruiting |
NCT02539693 -
Sacrococcygeal Local Anesthesia With Different Doses of Clonidine for Pilonidal Sinus Surgery
|
N/A | |
Completed |
NCT01081522 -
A Preliminary, Non-comparative Study to Evaluate a Bioresorbable Wound Scaffold in Acute Wounds
|
N/A | |
Completed |
NCT00997048 -
Comparison Between Laying Open and Sinus Excision of Pilonidal Sinus - a Randomized Study
|
N/A | |
Not yet recruiting |
NCT04273997 -
Metronidazole Ointment in Non-healing Pilonidal Sinus Wounds
|
Phase 2 | |
Recruiting |
NCT06324656 -
The Efficacy of Combining Platelet-rich Plasma With Crystallized Phenol in Pilonidal Sinus Disease
|
N/A | |
Completed |
NCT02246192 -
Use of Plasma Rich in Growth Factors (PRGF) in Pilonidal Sinus Excision
|
N/A | |
Completed |
NCT01662765 -
Conservative Versus Surgical Treatment of Umbilical Pilonidal Disease
|
N/A | |
Completed |
NCT06206330 -
Effect of Platelet Rich Plasma (PRP) on Healing Time in Patients Following Pilonidal Sinus Surgery
|
N/A | |
Recruiting |
NCT04217824 -
Comparison of Karydakis and Limberg Flap Treatment of Pilonidal Sinus in Adolescent. a Prospective, Randomised Study
|
N/A | |
Recruiting |
NCT03483480 -
Non-Powered Negative Pressure Wound Therapy vs Open Technique for Pilonidal Disease
|
N/A | |
Not yet recruiting |
NCT06140199 -
Comparing Minimally Invasive Treatments for Pilonidal Disease: LA POPA Trial (Laser And Pit-picking OR Pit-picking Alone)
|
N/A | |
Not yet recruiting |
NCT06286397 -
Topical Anti-Androgens in Pilonidal Sinus Disease
|
Phase 2 | |
Not yet recruiting |
NCT06406621 -
Laser Hair Depilation Darker Skin Pilonidal Disease
|
N/A | |
Completed |
NCT03923621 -
Pilonidal Excision Versus Endoscopic Surgery
|
N/A | |
Active, not recruiting |
NCT01792557 -
Crystallized Phenol Versus Transposition Flaps for Treatment of Pilonidal Disease: A Prospective Study
|
N/A |